Tag Archives: theranostics

Molecular Radiotherapy
4
Feb

Overview

Molecular radiotherapy uses radiolabeled agents to treat disease. It delivers targeted radiation to tumors and other lesions. It combines diagnostic imaging with therapy planning.

Clinical Indications

Theranostic pairs match diagnostic tracers with therapeutic agents. Indications include neuroendocrine tumors and prostate cancer. Patient selection and dosimetry are critical for safety.

Delivery and Monitoring

Imaging monitors distribution and response to therapy. Dosimetry guides treatment planning and follow up. Multidisciplinary teams coordinate care and manage toxicity.

Future Prospects

New agents and delivery methods expand therapeutic options. Personalized dosimetry improves efficacy and safety. Research aims to broaden indications and access.

Nuclear Medicine Journal
4
Feb

Overview

Nuclear Medicine Journal focuses on tracer development theranostics and quantitative PET SPECT methods; it highlights translational studies and clinical trials; articles emphasize dosimetry standardization and multicenter harmonization.

Tracer Development

Papers describe novel radiotracers for oncology neurology and cardiology; radiochemistry methods and production logistics are detailed; clinical translation challenges and regulatory pathways are discussed.

Quantification and Standards

Studies address SUV harmonization kinetic modeling and cross center calibration; guidelines for quantitative PET SPECT are proposed and validated; reproducible methods and phantom based QA are emphasized.

Theranostics and Therapy

Research on targeted radiopharmaceutical therapy and imaging biomarkers is featured; clinical outcomes safety and patient selection criteria are reported; multidisciplinary collaboration with oncology is highlighted.

Nuclear Medicine Magazine
4
Feb

Overview

Nuclear Medicine Magazine covers tracer development theranostics and quantitative imaging; it highlights clinical trials and translational research; articles support nuclear medicine physicians and technologists.

Tracer Innovation

Features describe novel PET and SPECT tracers for oncology and neurology; radiochemistry and logistics are discussed; clinical translation challenges are explored.

Theranostics

Coverage includes targeted radiopharmaceutical therapy and patient selection; safety and dosimetry considerations are presented; outcomes and case series illustrate therapeutic impact.

Quantitative Practice

Articles address SUV harmonization kinetic modeling and cross center calibration; best practices for quantitative PET are shared; readers learn methods to improve reproducibility.

Royal Marsden Hospital Imaging
4
Feb

Overview

Royal Marsden imaging provides dedicated oncologic imaging services with emphasis on clinical trials and novel imaging agents.

Specialties

Strengths in PET CT MRI and early phase imaging studies for novel therapeutics.

Research and Education

Collaborates with research institutes to translate imaging biomarkers into clinical trials and practice.

Notable Programs

Known for early adoption of theranostics and multidisciplinary cancer care pathways.